ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 2888

$1.3M Total Retail Price of All Prescriptions

Rank: 113 out of 2888

819 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 819 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 16,248 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 882 784 1 2
AMLODIPINE BESYLATE 780 685 2 5
OMEPRAZOLE 731 596 3 7
LEVOTHYROXINE SODIUM 675 600 4 1
NEXIUM 550 481 5 19
ZOLPIDEM TARTRATE 461 371 6 17
ATORVASTATIN CALCIUM 456 373 7 9
METOPROLOL TARTRATE 443 394 8 10
METFORMIN HCL 442 329 9 8
DOXAZOSIN MESYLATE 422 393 10 94
LOSARTAN POTASSIUM 386 336 11 18
FUROSEMIDE 337 272 12 6
TRAMADOL HCL-ACETAMINOPHEN 315 262 13 95
METOPROLOL SUCCINATE 304 276 14 11
HYDROCODONE-ACETAMINOPHEN 302 225 S3 15 4
PRAVASTATIN SODIUM 292 238 16 12
GABAPENTIN 292 255 16 13
FLUTICASONE PROPIONATE 284 225 18 32
GLYBURIDE 270 225 R 19 58
GLIMEPIRIDE 222 201 20 36
LISINOPRIL 219 184 21 3
ALENDRONATE SODIUM 215 204 22 23
INSULIN SYRINGE 215 168 22 86
MELOXICAM 210 174 24 31
NAMENDA 206 199 25 34
TAMSULOSIN HCL 201 189 26 29
DIOVAN 185 162 27 35
CITALOPRAM HBR 178 164 28 24
CEFUROXIME 177 169 29 130
LANTUS 166 141 30 45
GLYBURIDE-METFORMIN HCL 162 135 R 31 64
LOSARTAN-HYDROCHLOROTHIAZIDE 161 154 32 46
CLOPIDOGREL 158 103 33 30
CIPROFLOXACIN HCL 148 119 34 47
TRAMADOL HCL 147 134 35 16
RAMIPRIL 138 108 36 73
EXFORGE 134 128 37 159
CRESTOR 133 120 38 20
POLYETHYLENE GLYCOL 3350 132 126 39 93
GLIPIZIDE 125 96 40 50
ATENOLOL 122 105 41 25
VENLAFAXINE HCL ER 117 87 42 120
CYCLOBENZAPRINE HCL 116 72 R 43 68
PANTOPRAZOLE SODIUM 112 79 44 33
PRAMIPEXOLE DIHYDROCHLORIDE 107 81 45 202
ISOSORBIDE MONONITRATE ER 105 84 46 51
ACTOS 101 78 47 108
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 78 48 88
AMLODIPINE BESYLATE-BENAZEPRIL 98 95 48 67
SERTRALINE HCL 97 75 50 27
MECLIZINE HCL 96 81 51 122
PLAVIX 89 62 52 40
ENALAPRIL MALEATE 88 68 53 49
SURE COMFORT 88 81 53 276
FAMOTIDINE 86 83 55 75
DIOVAN HCT 85 70 56 61
HYDROCHLOROTHIAZIDE 85 85 56 15
HUMULIN 70-30 83 61 58 230
BUPROPION XL 83 57 58 212
AZITHROMYCIN 82 62 60 38
ESCITALOPRAM OXALATE 79 76 61 62
DOXYCYCLINE HYCLATE 78 50 62 123
LOVAZA 78 57 62 97
POTASSIUM CHLORIDE 78 73 62 14
LYRICA 74 68 65 69
CEPHALEXIN 74 63 65 119
CARVEDILOL 70 40 67 21
LEVEMIR 61 37 68 135
WARFARIN SODIUM 60 59 69 22
ACTONEL 60 58 69 149
SPIRONOLACTONE 59 45 71 70
DONEPEZIL HCL 58 53 72 26
MONTELUKAST SODIUM 58 40 72 153
VENLAFAXINE HCL 57 46 74 246
TRICOR 56 34 75 91
OXYBUTYNIN CHLORIDE 55 55 76 124
JANTOVEN 55 52 76 163
PHENYTOIN SODIUM EXTENDED 55 29 76 128
SINGULAIR 54 39 79 85
PEN NEEDLE 52 29 80 110
CLOTRIMAZOLE-BETAMETHASONE 52 39 80 136
PIOGLITAZONE HCL 52 41 R 80 248
NOVOLOG MIX 70-30 50 46 83 209
CYMBALTA 50 47 83 44
HYDRALAZINE HCL 50 49 83 59
DILTIAZEM ER 50 46 83 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.